Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 7, 2010, Pages 1049-1058

  Del Casar, José M ^a,b   Carreño, Guillermo ^c   González, Luis O ^a,b   Junquera, Sara ^a   González Reyes, Salomé ^a   González, José M ^a   Bongera, Miguel ^a   Merino, Antonio M ^b,c   Vizoso, Francisco J ^a,b  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

Author keywords

Breast cancer; Local recurrence; MMPs; TIMPs; Tissue arrays

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN 3; TAMOXIFEN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; TISSUE MICROARRAY; TUMOR GROWTH;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 77953229042     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0750-x     Document Type: Article

References (82)

1. WJ Aberizk B Silver IC Henderson B Cady JR Harris 1986 The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy Cancer 58 1214 1218 10.1002/1097-0142(19860915)58: 6<1214:AID-CNCR2820580607>3.0.CO;2-9 1:STN:280:DyaL283pvVSlug%3D%3D 3742446
2. JW Alexander WA Altemeier 1964 Susceptibility of injured tissues to hematogenous metastases: an experimental study Ann Surg 159 933 944 10.1097/00000658-196406000-00010 1:STN:280:DyaF2c7ivVaksA%3D%3D 14170294
3. H Auchincloss Jr 1958 The nature of local recurrence following radical mastectomy Cancer 11 611 619 10.1002/1097-0142(195805/06)11:3<611:AID- CNCR2820110323>3.0.CO;2-B 13523570
4. AH Baker SJ George AB Zaltsman G Murphy AC Newby 1999 Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3 Br J Cancer 79 1347 1355 10.1038/sj.bjc.6690217 1:CAS:528:DyaK1MXitFGku78%3D 10188875
5. EA Baker TJ Stephenson MW Reed NJ Brown 2002 Expression of proteinases and inhibitors in human breast cancer progression and survival Mol Pathol 55 300 304 10.1136/mp.55.5.300 1:CAS:528:DC%2BD38XovFKhu7w%3D 12354933 (Pubitemid 35193256)
6. E Baral S Ogenstad A Wallgren 1985 The effect of adjuvant radiotherapy on the time of occurrence and prognosis of local recurrence in primary operable breast cancer Cancer 56 2779 2782 10.1002/1097-0142(19851215)56:12<2779:AID- CNCR2820561210>3.0.CO;2-C 1:STN:280:DyaL28%2FislKkuw%3D%3D 4052951
7. R Barnes S Masood E Barker, et al. 1991 Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival Am J Pathol 139 245 250 1:STN:280:DyaK3MzivVaqtg%3D%3D 1714241
8. J Bedwinek 1994 Natural history and management of isolated local-regional recurrence following mastectomy Semin Radiat Oncol 4 260 269 10.1016/S1053-4296(05)80097-9 10717115 (Pubitemid 24312247)
9. JM Bedwinek J Lee B Fineberg M Ocwieza 1981 Prognostic indicators in patients with isolated local-regional recurrence of breast cancer Cancer 47 2232 2235 10.1002/1097-0142(19810501)47:9<2232:AID-CNCR2820470921>3.0.CO;2-R 1:STN:280:DyaL3M7os1Sltw%3D%3D 7226118 (Pubitemid 11098595)
10. DA Berstock J Houghton J Haybittle M Baum 1985 The role of radiotherapy following total mastectomy for patients with early breast cancer World J Surg 9 667 670 10.1007/BF01655178 1:STN:280:DyaL28%2Fks1akuw%3D%3D 4060744 (Pubitemid 15241689)
11. M Borner M Bacchi A Goldhirsch, et al. 1994 First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research J Clin Oncol 12 2071 2077 1:STN:280:DyaK2M%2Fhs1yksg%3D%3D 7931476
12. G Carreno JM Del Casar MD Corte, et al. 2007 Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics Breast Cancer Res Treat 102 61 73 10.1007/s10549-006-9310-0 16850244 (Pubitemid 46294960)
13. CF Chantrain H Shimada S Jodele, et al. 2004 Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment Cancer Res 64 1675 1686 10.1158/0008-5472.CAN-03- 0160 1:CAS:528:DC%2BD2cXhslekur0%3D 14996727 (Pubitemid 38428689)
14. LA Cornelius LC Nehring E Harding, et al. 1998 Matrix metalloproteinases generate angiostatin: effects on neovascularization J Immunol 161 6845 6852 1:CAS:528:DyaK1cXotFWqtbk%3D 9862716
15. G Crile Jr 1972 Low incidence and morbidity of local recurrence after conservative operations for cancer of the breast Ann Surg 175 249 253 10.1097/00000658-197202000-00015 5059608
16. TL Dao T Nemoto 1963 The clinical significance of skin recurrence after radical mastectomy in women with cancer of the breast Surg Gynecol Obstet 117 447 453 1:STN:280:DyaF2c%2FitlemtQ%3D%3D 14065726
17. TL Dao H Yogo 1967 Enhancement of pulmonary metastases by x-irradiation in rats bearing mammary cancer Cancer 20 2020 2025 10.1002/1097-0142(196711)20: 11<2020:AID-CNCR2820201131>3.0.CO;2-8 1:STN:280:DyaF1c%2FlsFantw%3D%3D 6061636
18. AR Dixon IO Ellis CW Elston RW Blamey 1991 A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast Br J Cancer 63 634 635 1:STN:280:DyaK3M3hsVygsA%3D%3D 1850613
19. WL Donegan CM Perez-Mesa FR Watson 1966 A biostatistical study of locally recurrent breast carcinoma Surg Gynecol Obstet 122 529 540 1:STN:280: DyaF287gslaqsQ%3D%3D 5908662
20. Z Dong R Kumar X Yang IJ Fidler 1997 Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma Cell 88 801 810 10.1016/S0092-8674(00)81926-1 1:CAS:528:DyaK2sXitFyqsbw%3D 9118223 (Pubitemid 27164268)
21. MJ Duffy TM Maguire A Hill E McDermott N O'Higgins 2000 Metalloproteinases: role in breast carcinogenesis, invasion and metastasis Breast Cancer Res 2 252 257 10.1186/bcr65 1:CAS:528:DC%2BD3cXlvFOgs7Y%3D 11250717 (Pubitemid 32223594)
22. GC Durkan JE Nutt C Marsh, et al. 2003 Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer Clin Cancer Res 9 2576 2582 1:CAS:528:DC%2BD3sXlt1yrsr0%3D 12855633
23. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 10.1038/nrc745 1:CAS:528: DC%2BD38Xis1KktL8%3D 11990853
24. M Ferreras U Felbor T Lenhard BR Olsen J Delaisse 2000 Generation and degradation of human endostatin proteins by various proteinases FEBS Lett 486 247 251 10.1016/S0014-5793(00)02249-3 1:CAS:528:DC%2BD3cXovFGru7s%3D 11119712
25. IJ Fidler I Zeidman 1972 Enhancement of experimental metastasis by X-ray: a possible mechanism J Med 3 172 177 1:STN:280:DyaE3s%2FktlGnuw%3D%3D 4508256
26. B Fingleton T Vargo-Gogola HC Crawford LM Matrisian 2001 Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis Neoplasia 3 459 468 10.1038/sj.neo.7900190 1:CAS:528:DC%2BD38XksFKjsg%3D%3D 11774028 (Pubitemid 33151012)
27. B Fisher ER Fisher 1959 Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury Ann Surg 150 731 744 10.1097/00000658-195910000-00015 1:STN:280:DyaF3c7ktlKlsw%3D%3D 13823186
28. B Fisher C Redmond ER Fisher 1980 The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology-an overview of findings Cancer 46 1009 1025 10.1002/1097-0142(19800815) 46:4+<1009:AID-CNCR2820461326>3.0.CO;2-H 1:STN:280:DyaL3c3ktlyrtg%3D%3D 6994873
29. MD Gilliland RM Barton EM Copeland 3rd 1983 The implications of local recurrence of breast cancer as the first site of therapeutic failure Ann Surg 197 284 287 10.1097/00000658-198303000-00007 1:STN:280:DyaL3s7ltFyktg%3D%3D 6830336
30. LO Gonzalez I Pidal S Junquera, et al. 2007 Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse Br J Cancer 97 957 963 10.1038/sj.bjc.6603935 1:CAS:528:DC%2BD2sXhtFSnurbL 17848954 (Pubitemid 47396286)
31. F Grieu WQ Li B Iacopetta 2004 Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype Breast Cancer Res Treat 88 197 204 10.1007/s10549-004-0595-6 1:CAS:528:DC%2BD2MXht1Kjt70%3D 15609121 (Pubitemid 40137297)
32. Y Jiang ID Goldberg YE Shi 2002 Complex roles of tissue inhibitors of metalloproteinases in cancer Oncogene 21 2245 2252 10.1038/sj.onc.1205291 1:CAS:528:DC%2BD38XivFyntbw%3D 11948407 (Pubitemid 34311378)
33. JL Jones RA Walker 1997 Control of matrix metalloproteinase activity in cancer J Pathol 183 377 379 10.1002/(SICI)1096-9896(199712)183:4<377:AID- PATH951>3.0.CO;2-R 1:STN:280:DyaK1c7lslegtQ%3D%3D 9496252
34. JL Jones P Glynn RA Walker 1999 Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas J Pathol 189 161 168 10.1002/(SICI)1096-9896(199910)189:2<161:AID-PATH406>3.0.CO;2-2 1:CAS:528:DyaK1MXms12mtLo%3D 10547569
35. S Kaae H Johansen 1962 Breast cancer; five year results: two random series of simple mastectomy with postoperative irradiation versus extended radical mastectomy Am J Roentgenol Radium Ther Nucl Med 87 82 88 1:STN:280:DyaF38%2FlsVegtg%3D%3D 14452927
36. C Kamby L Sengelov 1999 Survival and pattern of failure following locoregional recurrence of breast cancer Clin Oncol (R Coll Radiol) 11 156 163 1:STN:280:DyaK1MzptlWmuw%3D%3D
37. C Kamby J Andersen B Ejlertsen, et al. 1991 Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer Acta Oncol 30 301 308 10.3109/02841869109092375 1:STN:280:DyaK3M3kt1WntQ%3D%3D 2036238
38. S Karabali-Dalamaga RL Souhami NJ O'Higgins A Soumilas CG Clark 1978 Natural history and prognosis of recurrent breast cancer Br Med J 2 730 733 10.1136/bmj.2.6139.730 1:STN:280:DyaE1M%2Fit1ertA%3D%3D 698698
39. J Lacour M Le E Caceres T Koszarowski U Veronesi C Hill 1983 Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer Cancer 51 1941 1943 10.1002/1097-0142(19830515)51:10<1941:AID-CNCR2820511032>3.0.CO;2-T 1:STN:280:DyaL3s7lsFSksA%3D%3D 6339026
40. J Lacour MG Le C Hill A Kramar G Contesso D Sarrazin 1987 Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 13 309 314 1:STN:280:DyaL2szgsVylsg%3D%3D 3305080
41. HC Li DC Cao Y Liu, et al. 2004 Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma Breast Cancer Res Treat 88 75 85 10.1007/s10549-004-1200-8 1:CAS:528:DC%2BD2cXpsF2msbk%3D 15538048 (Pubitemid 39524447)
42. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379 10.1038/35077241 1:CAS:528:DC%2BD3MXktVSjs78%3D 11357145 (Pubitemid 32467047)
43. S Manes M Llorente RA Lacalle, et al. 1999 The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells J Biol Chem 274 6935 6945 10.1074/jbc.274.11.6935 1:CAS:528:DyaK1MXhvFWqsb0%3D 10066747 (Pubitemid 29140501)
44. K McCarthy T Maguire G McGreal E McDermott N O'Higgins MJ Duffy 1999 High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer Int J Cancer 84 44 48 10.1002/(SICI)1097- 0215(19990219)84:1<44:AID-IJC9>3.0.CO;2-P 1:STN:280:DyaK1M7ktVOgsg%3D%3D 9988231
45. K Mimori H Ueo C Shirasaka M Mori 2001 Clinical significance of MT1-MMP mRNA expression in breast cancer Oncol Rep 8 401 403 1:CAS:528: DC%2BD3MXit1anu70%3D 11182063
46. L Nakopoulou I Giannopoulou K Stefanaki, et al. 2002 Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis J Pathol 197 307 313 10.1002/path.1129 1:CAS:528:DC%2BD38XmtVSkur0%3D 12115876 (Pubitemid 34778300)
47. BS Nielsen F Rank JM Lopez, et al. 2001 Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas Cancer Res 61 7091 7100 1:CAS:528:DC%2BD3MXnsVehs7Y%3D 11585740
48. V Noe B Fingleton K Jacobs, et al. 2001 Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 J Cell Sci 114 111 118 1:CAS:528:DC%2BD3MXhtVSgsL8%3D 11112695
49. SG Orel MD Schnall CM Powell, et al. 1995 Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy Radiology 196 115 122 1:STN:280:DyaK2MzgsVSisw%3D%3D 7784554
50. AN Papaioannou 1985 Hypothesis: increasingly intensive locoregional treatment of breast cancer may promote recurrence J Surg Oncol 30 33 41 10.1002/jso.2930300111 1:STN:280:DyaL28%2FptVGnsA%3D%3D 4079416 (Pubitemid 16249419)
51. RL Parker DG Huntsman DW Lesack, et al. 2002 Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray Am J Clin Pathol 117 723 728 10.1309/PEF8-GL6F-YWMC-AG56 12090420 (Pubitemid 34457006)
52. JM Pellikainen KM Ropponen VV Kataja JK Kellokoski MJ Eskelinen VM Kosma 2004 Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis Clin Cancer Res 10 7621 7628 10.1158/1078-0432.CCR-04-1061 1:CAS:528:DC%2BD2cXhtVanurzI 15569994 (Pubitemid 39557525)
53. A Pineiro J Salinas J Illana, et al. 2004 Locoregional recurrence and metastasis in the long-term follow-up of postmastectomy breast cancer patients with T1-T2 tumors and one to three positive lymph nodes Rev Oncol 6 341 346
54. TM Pisansky JN Ingle DJ Schaid, et al. 1993 Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors Cancer 72 1247 1260 10.1002/1097-0142(19930815)72:4<1247: AID-CNCR2820720418>3.0.CO;2-S 1:STN:280:DyaK3szjvVKjug%3D%3D 8339215
55. AH Ree VA Florenes JP Berg GM Maelandsmo JM Nesland O Fodstad 1997 High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases Clin Cancer Res 3 1623 1628 1:STN:280:DyaK1M7htFWjsw%3D%3D 9815852
56. A Remacle K McCarthy A Noel, et al. 2000 High levels of TIMP-2 correlate with adverse prognosis in breast cancer Int J Cancer 89 118 121 10.1002/(SICI)1097-0215(20000320)89:2<118:AID-IJC3>3.0.CO;2-8 1:CAS:528:DC%2BD3cXislehsr0%3D 10756061
57. DB Rifkin R Mazzieri JS Munger I Noguera J Sung 1999 Proteolytic control of growth factor availability Apmis 107 80 85 10.1111/j.1699-0463.1999.tb01529.x 1:CAS:528:DyaK1MXitFals7s%3D 10190283
58. DL Rimm RL Camp LA Charette J Costa DA Olsen M Reiss 2001 Tissue microarray: a new technology for amplification of tissue resources Cancer J 7 24 31 1:STN:280:DC%2BD3M7mslKjsA%3D%3D 11269645
59. EF Scanlon 1985 Local recurrence in the pectoralis muscles following modified radical mastectomy for carcinoma J Surg Oncol 30 149 151 1:STN:280:DyaL28%2FptVGltg%3D%3D 4079434
60. AS Schrohl IJ Christensen AN Pedersen, et al. 2003 Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer Mol Cell Proteomics 2 164 172 10.1074/mcp.M300019-MCP200 1:CAS:528:DC%2BD3sXjs1yjtL8%3D 12672830
61. AS Schrohl MN Holten-Andersen HA Peters, et al. 2004 Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer Clin Cancer Res 10 2289 2298 10.1158/1078-0432.CCR-03-0360 1:CAS:528:DC%2BD2cXivFSqsrg%3D 15073104 (Pubitemid 38445686)
62. A Schuck S Konemann B Matthees, et al. 2002 Radiotherapy in the treatment of locoregional relapses of breast cancer Br J Radiol 75 663 669 1:STN:280:DC%2BD38vgsVarug%3D%3D 12153940
63. A Sivula A Talvensaari-Mattila J Lundin, et al. 2005 Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer Breast Cancer Res Treat 89 215 220 10.1007/s10549-004-0714-4 1:CAS:528:DC%2BD2MXitVKlsb4%3D 15754118 (Pubitemid 43293067)
64. D Skipper MJ Jeffrey AJ Cooper P Alexander I Taylor 1989 Enhanced growth of tumour cells in healing colonic anastomoses and laparotomy wounds Int J Colorectal Dis 4 172 177 10.1007/BF01649697 1:STN:280:DyaL1MzmtV2itQ%3D%3D 2769000
65. JS Spratt 1967 Locally recurrent cancer after radical mastectomy Cancer 20 1051 1053 10.1002/1097-0142(196707)20:7<1051:AID-CNCR2820200705>3.0. CO;2-D 1:STN:280:DyaF2s7mvV2msQ%3D%3D 6026999
66. D Stefanik R Goldberg P Byrne, et al. 1985 Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer J Clin Oncol 3 660 665 1:STN:280:DyaL2M3gvF2rug%3D%3D 3998783
67. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 463 516 10.1146/annurev.cellbio.17.1.463 1:CAS:528:DC%2BD3MXos1Omsbs%3D 11687497 (Pubitemid 33096184)
68. WG Stetler-Stevenson 1999 Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J Clin Invest 103 1237 1241 10.1172/JCI6870 1:CAS:528:DyaK1MXivFansrk%3D 10225966
69. HF Sykes DA Sim CJ Wong JR Cassady SE Salmon 1989 Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy Int J Radiat Oncol Biol Phys 16 641 647 1:STN:280:DyaL1M7lsFamtQ%3D%3D 2921164
70. WF Symmans M Ayers EA Clark, et al. 2003 Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma Cancer 97 2960 2971 10.1002/cncr.11435 1:CAS:528:DC%2BD3sXlt1Shtrw%3D 12784330 (Pubitemid 36676249)
71. A Talvensaari-Mattila P Paakko G Blanco-Sequeiros T Turpeenniemi-Hujanen 2001 Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy Breast Cancer Res Treat 65 55 61 10.1023/A:1006458601568 1:CAS:528:DC%2BD3MXhvFektbg%3D 11245340 (Pubitemid 32163500)
72. A Talvensaari-Mattila P Paakko T Turpeenniemi-Hujanen 2003 Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma Br J Cancer 89 1270 1275 10.1038/sj.bjc.6601238 1:CAS:528:DC%2BD3sXns1Cmur0%3D 14520459 (Pubitemid 37363416)
73. LM Toonkel I Fix LH Jacobson CB Wallach 1983 The significance of local recurrence of carcinoma of the breast Int J Radiat Oncol Biol Phys 9 33 39 1:STN:280:DyaL3s7osFGksA%3D%3D 6404864
74. V Turk J Kos B Turk 2004 Cysteine cathepsins (proteases)-on the main stage of cancer? Cancer Cell 5 409 410 10.1016/S1535-6108(04)00117-5 1:CAS:528:DC%2BD2cXksFCmt70%3D 15144947 (Pubitemid 38610242)
75. P Valagussa G Bonadonna U Veronesi 1978 Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients Cancer 41 1170 1178 10.1002/1097-0142(197803)41:3<1170:AID-CNCR2820410355>3.0.CO;2-I 1:STN:280:DyaE1c7ks1ajsA%3D%3D 638961
76. G van Tienhoven AC Voogd JL Peterse, et al. 1999 Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group Eur J Cancer 35 32 38 10.1016/S0959-8049(98)00301-3 10211085 (Pubitemid 29079488)
77. U Veronesi E Marubini M Del Vecchio, et al. 1995 Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events J Natl Cancer Inst 87 19 27 10.1093/jnci/87.1.19 1:STN:280:DyaK2MzpsFyrtw%3D%3D 7666458
78. DW Visscher M Hoyhtya SK Ottosen, et al. 1994 Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence Int J Cancer 59 339 344 10.1002/ijc.2910590308 1:CAS:528:DyaK2MXit1aqsbg%3D 7927938 (Pubitemid 24331823)
79. FJ Vizoso LO Gonzalez MD Corte, et al. 2007 Study of matrix metalloproteinases and their inhibitors in breast cancer Br J Cancer 96 903 911 10.1038/sj.bjc.6603666 1:CAS:528:DC%2BD2sXjt1Srsbw%3D 17342087 (Pubitemid 46452295)
80. FJ Vizoso M Rodriguez A Altadill, et al. 2007 Liver expression of steroid hormones and apolipoprotein D receptors in hepatocellular carcinoma World J Gastroenterol 13 3221 3227 1:CAS:528:DC%2BD2sXos1Cmsrs%3D 17589901
81. J Willner IC Kiricuta O Kolbl 1997 Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis Int J Radiat Oncol Biol Phys 37 853 863 1:STN:280:DyaK2s3nsFSlug%3D%3D 9128962
82. Q Yu I Stamenkovic 2000 Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis Genes Dev 14 163 176 10652271